Get started
Markets Denmark Stocks Health Technology Pharmaceuticals: Major

NOVO NORDISK B A/S NOVO_B

NOVO_B OMXCOP
NOVO_B
NOVO NORDISK B A/S OMXCOP
See more on advanced chartSee more on advanced chart
 
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
See more on advanced chartSee more on advanced chart
Overview
News Ideas Financials Technicals

NOVO_B Stock Chart

Get $150 worth of Bitcoin from TradeStation Crypto with a new account. Start trading

Ideas

Videos only
NOVO NORDISK B A/S Long short days
NOVO_B
, 1D
NOVO_B: NOVO NORDISK B A/S Long short days

NOVONORDISK B A/S Long short days volume

NOVO_B breack Long - short Days
NOVO_B
, 1D
NOVO_B: NOVO_B breack Long - short Days

NOVO_B breack Long - short Days

NOVO_B hours long
NOVO_B
, 60
Long
NOVO_B: NOVO_B hours long

NOVO NORDISK B A/S long hours

NOVO NORDISK B A/S long hours
NOVO_B
, 60
Long
NOVO_B: NOVO NORDISK B A/S long hours

NOVO NORDISK B A/S long hours

Novo Nordisk - Decision between two channels
NOVO_B
, 1W
NOVO_B: Novo Nordisk - Decision between two channels

Next months will show, where Novo Nordisk is heading. No position yet.

NOVO_B days
NOVO_B
, 1D
NOVO_B: NOVO_B days

NOVO_B days trend + volum+ vwap

NOVO_B up hours
NOVO_B
, 1D
Long
NOVO_B: NOVO_B up hours

My analysis of Novo long hours volume + VWAP

NOVO_B
NOVO_B
, 1D Short
NOVO_B: NOVO_B

NOVO_B Jeg tror på å falle i disse dager volume +vwap

bullish
NOVO_B
, 15
Long
NOVO_B: bullish

confirmation of buyers continuation

Novo Nordisk as of 6.12.2020
NOVO_B
, 1D
NOVO_B: Novo Nordisk as of 6.12.2020

My analysis of Novo Nordisk as of 6.12.2020 With the current recommendation for "buy" with my eyes (short term)

long - short term
NOVO_B
, 1D
Long
NOVO_B: long - short term

long

i recommand buying
NOVO_B
, 15
NOVO_B: i recommand buying

Follow me to get all the ideas.

Novo Nordisk Updated
NOVO_B
, 1D Short
NOVO_B: Novo Nordisk Updated

The last anaylsis of Novo Nordisk was successful at its prediction. Heres an updated one of where i see it in the short term future

I Recommend SELLING
NOVO_B
, 1D
NOVO_B: I Recommend SELLING

Technical indicators( candles ; volume ; ligne ; fbonaci ..) indicate a decline in the market during the next week; I advise you to sell and wait for the next buying signal

ORDER : BUY
NOVO_B
, 15 Short
NOVO_B: ORDER : BUY

ORDER : BUY

Novo Nordisk
NOVO_B
, 1D
NOVO_B: Novo Nordisk

Novo Nordisk

Long Term: looking for an entry point on this beautiful stock
NOVO_B
, 1W
Long
NOVO_B: Long Term: looking for an entry point on this beautiful stock

Novo Nordisk is one of the world leaders in the medical treatment of diabetes. It also researches, develops and markets treatments for obesity. It is a fast-growing sector with the rise of fast food and the development of emerging countries. However, the field is becoming more and more competitive, especially in the US, which has meant slower growth for the...

sell
NOVO_B
, 1D Short
NOVO_B: sell

sell

Show more ideas

Technicals

Financials

Valuation
Enterprise Value/EBITDA, TTM —
Enterprise Value, FQ —
Market Cap — Basic —
Number of Employees —
Number of Shareholders —
Price/Earnings, TTM —
Price/Revenue, TTM —
Price/Book Ratio, FY —
Price/Sales Ratio, FY —
Balance Sheet
Current Ratio, FQ —
Debt to Equity, FQ —
Net Debt, FQ —
Quick Ratio, FQ —
Total Assets, FQ —
Total Debt, FQ —
Operating Metrics
Return on Assets, TTM —
Return on Equity, TTM —
Return on Invested Capital, TTM —
Revenue per Employee, TTM —
Price History
Average Volume (10 day) —
Beta - 1 Year —
Price - 52 Week High —
Price - 52 Week Low —
Dividends
Dividends Paid, FY —
Dividends per Share, FY —
Expected Annual Dividends —
Dividends Yield —
Margins
Net Margin, TTM —
Gross Margin, TTM —
Operating Margin, TTM —
Pretax Margin, TTM —
Income Statement
Basic EPS, Net Income —
Earnings per Share, Basic, TTM —
EBITDA, TTM —
Gross Profit, FY —
Last Annual EPS —
Last Annual Revenue, FY —
Net Income, FY —
Total Revenue, FY —
Free Cash Flow, TTM —
More financials

Profile

Sector: Health Technology
Industry: Pharmaceuticals: Major
Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. It operates through the following segments: Diabetes & Obesity Care, and Biopharmaceuticals. The Diabetes & Obesity Care segment covers products for insulin; GLP-1 and related delivery systems; oral antidiabetic products; and obesity. The Biopharmaceuticals segment offers products for haemophilia; growth hormone therapy; and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.

Breaking news

More news